{
    "clinical_study": {
        "@rank": "92307", 
        "arm_group": [
            {
                "arm_group_label": "Open Resection  Group", 
                "description": "Colon cancer survivors who undergo open surgical resection of their colon cancers."
            }, 
            {
                "arm_group_label": "Laparoscopic Resection Group", 
                "description": "Colon cancer survivors who undergo laparoscopic resection of their colon cancer"
            }, 
            {
                "arm_group_label": "Robotic Resection Group", 
                "description": "Colon cancer survivors who undergo robotic resection of their colon cancer."
            }
        ], 
        "brief_summary": {
            "textblock": "The overall purpose of this study is to describe the trajectory of early survivorship in\n      individuals with colon cancer who undergo both surgical and medical management of colon\n      cancer. The primary question is whether or not there is an interaction between type of\n      surgery and changes in quality of life, sexual function, peripheral neuropathy, and demands\n      of illness following curative resection and adjuvant chemotherapy."
        }, 
        "brief_title": "The Inland Northwest Colon Cancer Survivor's Study", 
        "completion_date": {
            "#text": "June 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Colon Cancer", 
        "condition_browse": {
            "mesh_term": [
                "Colonic Neoplasms", 
                "Peripheral Nervous System Diseases"
            ]
        }, 
        "detailed_description": {
            "textblock": "The prospective design with three cohorts of participants will describe the changes in\n      quality of life, sexual function, peripheral neuropathy and demands of illness following\n      curative resection and adjuvant chemotherapy (Aims 1-4). An analysis of the interaction\n      between time (four measurement occasions) and surgical type (open resection, laparoscopic\n      resection, robotic resection) by mean values of quality of life, sexual function, peripheral\n      neuropathy, and demands of illness will examine the central thesis question (Aim 5).\n\n      Specific Aims\n\n        1. Describe the demographic and disease characteristics of the sample.\n\n        2. Examine the relationships among quality of life, sexual functioning,   peripheral\n           neuropathy, and demands of illness for the sample-as-a-whole and by type of surgical\n           resection (open, laparoscopic, robotic).\n\n        3. Examine within-subject changes in the mean values of scores for quality of life, sexual\n           functioning, peripheral neuropathy, and demands of illness across four measurement\n           occasions.\n\n        4. Examine between-group differences in mean values of scores for quality of life, sexual\n           function, peripheral neuropathy, and demands of illness at four   discrete measurement\n           occasions.\n\n        5. Examine the interaction between time (four measurement occasions) and surgical type\n           (open resection, laparoscopic resection, robotic resection) by mean values of quality\n           of life, sexual function, peripheral neuropathy, and demands of illness."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Male or Female at least 18 years of age\n\n          -  Biopsy Proven Colon Cancer\n\n          -  Plan to undergo open, laparoscopic or robotic surgical colectomy.\n\n        Exclusion Criteria:\n\n          -  Persons with rectal cancer\n\n          -  Surgical resection below the rectal sigmoid junction\n\n          -  Does not speak or read English\n\n          -  Scheduled to receive radiation therapy during the data collection period\n\n          -  Diagnosis of metastatic colon cancer (Stage IV)\n\n          -  A previous history of cancer diagnosed with the past five years with the exception of\n             early basal cell or squamous skin cancer or early stage melanoma"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Persons newly diagnosed with colon cancer anticipated to undergo curative resection. To\n        include those who will receive adjuvant FOLFOX chemotherapy."
            }
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 23, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01775254", 
            "org_study_id": "DSCN-11-194-01"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Colon Cancer", 
            "FOLFOX", 
            "Laparoscopic Colectomy", 
            "Open Colectomy", 
            "Robotic Colectomy", 
            "Quality of Life", 
            "Sexual Function", 
            "Peripheral Neuropathy", 
            "Demands of Illness", 
            "Cancer Survivor"
        ], 
        "lastchanged_date": "January 31, 2013", 
        "location": [
            {
                "contact": {
                    "email": "jeanne.robison@email.wsu.edu", 
                    "last_name": "Jeanne M Robison, ARNP", 
                    "phone": "509-475-6502"
                }, 
                "facility": {
                    "address": {
                        "city": "Spokane", 
                        "country": "United States", 
                        "state": "Washington", 
                        "zip": "99204"
                    }, 
                    "name": "Sacred Heart Medical Center"
                }, 
                "investigator": {
                    "last_name": "Jeanne M Robison, ARNP", 
                    "role": "Sub-Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "jeanne.robison@email.wsu.edu", 
                    "last_name": "Jeanne M Robison, ARNP", 
                    "phone": "509-475-6502"
                }, 
                "facility": {
                    "address": {
                        "city": "Spokane", 
                        "country": "United States", 
                        "state": "Washington", 
                        "zip": "99204"
                    }, 
                    "name": "Deaconess Hospital"
                }, 
                "investigator": {
                    "last_name": "Jeanne M Robison, ARNP", 
                    "role": "Sub-Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "jeanne.robison@email.wsu.edu", 
                    "last_name": "Jeanne M Robison, ARNP", 
                    "phone": "509-476-6502"
                }, 
                "facility": {
                    "address": {
                        "city": "Spokane", 
                        "country": "United States", 
                        "state": "Washington", 
                        "zip": "99208"
                    }, 
                    "name": "Holy Family Hospital"
                }, 
                "investigator": {
                    "last_name": "Jeanne M Robison, ARNP", 
                    "role": "Sub-Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "jeanne.robison@email.wsu.edu", 
                    "last_name": "Jeanne M Robison, ARNP", 
                    "phone": "509-475-6502"
                }, 
                "facility": {
                    "address": {
                        "city": "Spokane", 
                        "country": "United States", 
                        "state": "Washington", 
                        "zip": "99216"
                    }, 
                    "name": "Valley Hospital"
                }, 
                "investigator": {
                    "last_name": "Jeanne M Robison, ARNP", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "3", 
        "official_title": "Self Reported Changes in Quality of Life, Sexual Function, Peripheral Neuropathy, and Demands of Illness, Following Curative Resection and Adjuvant FOLFOX Chemotherapy in Colon Cancer Survivors", 
        "other_outcome": {
            "description": "Psychometric analysis to evaluate the reliability and validity of the modified Neurotoxicity Sub-Scale.", 
            "measure": "Psychometric analysis of a modified version of the Neurotoxicity Sub-scale.", 
            "safety_issue": "No", 
            "time_frame": "At the completion of the study"
        }, 
        "overall_contact": {
            "email": "jeanne.robison@email.wsu.edu", 
            "last_name": "Jeanne M Robison, MN, ARNP", 
            "phone": "509-475-6502"
        }, 
        "overall_contact_backup": {
            "email": "mel.haberman@wsu.edu", 
            "last_name": "Mel Haberman, PhD, FAAN", 
            "phone": "509-324-7358"
        }, 
        "overall_official": [
            {
                "affiliation": "Washington State University, College of Nursing", 
                "last_name": "Jeanne M Robison, MN, ARNP", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Washington State University, College of Nursing", 
                "last_name": "Mel Haberman, PhD, FAAN", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The European Organization for Research and Treatment Quality of Life Questionnaire (EORTC-QLQ-C-30) and colon cancer specific module (QLQ-CR-29)will be utilized to measure changes in quality of life. The interaction between time (four measurement occasions) and surgical type (open resection, laparoscopic resection, robotic resection) by mean values of quality of life will be examined.", 
            "measure": "Quality of Life", 
            "safety_issue": "No", 
            "time_frame": "Four  measurements occasions over 38 weeks  (Before surgery, 4-6  weeks after surgery, 20-22 weeks after surgery and 32-36 weeks after surgery)"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01775254"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "The Neurotoxicity Sub-scale (Ntx-13); a questionnaire about symptoms of nerve damage in persons receiving chemotherapy, will be utilized to assess symptoms of neurologic toxicities in persons receiving the chemotherapy drug oxaliplatin. The interaction between time (four measurement occasions) and surgical type (open resection, laparoscopic resection, robotic resection) by mean values of peripheral neuropathy will be examined.", 
                "measure": "Peripheral Neuropathy", 
                "safety_issue": "No", 
                "time_frame": "Four measurements occasions over 38 weeks (Before surgery, 4-6 weeks after surgery, 20-22 weeks after surgery and 32-36 weeks after surgery)"
            }, 
            {
                "description": "The Changes in Sexual Function Questionnaire (CSFQ)will be used to describe the changes in sexual function reported by cancer survivors following surgery and adjuvant chemotherapy. The interaction between time (four measurement occasions) and surgical type (open resection, laparoscopic resection, robotic resection) by mean values of changes in sexual function will be examined.", 
                "measure": "Changes in Sexual Function", 
                "safety_issue": "No", 
                "time_frame": "Four measurements occasions over 38 weeks (Before surgery, 4-6 weeks after surgery, 20-22 weeks after surgery and 32-36 weeks after surgery)"
            }, 
            {
                "description": "The Demands of Illness Inventory (DOII); a questionnaire about the stressors experienced by cancer survivors will be utilized for this outcome measure. The interaction between time (four measurement occasions) and surgical type (open resection, laparoscopic resection, robotic resection) by mean values from the demands of illness inventory will be examined.", 
                "measure": "Demands of Illness", 
                "safety_issue": "No", 
                "time_frame": "Four measurements occasions over 38 weeks (Before surgery, 4-6 weeks after surgery, 20-22 weeks after surgery and 32-36 weeks after surgery)"
            }, 
            {
                "description": "A short questionnaire regarding the use of educational and support materials related to colon cancer will be used to describe which materials persons with colon cancer utilize during the 58 weeks after diagnosis.", 
                "measure": "Patient Education and Support", 
                "safety_issue": "No", 
                "time_frame": "Four measurements occasions over 38 weeks (Before surgery, 4-6 weeks after surgery, 20-22 weeks after surgery and 32-36 weeks after surgery)"
            }
        ], 
        "source": "Washington State University", 
        "sponsors": {
            "collaborator": {
                "agency": "American Cancer Society, Inc.", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Washington State University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "January 2013"
    }
}